Abstract
Background
The definition of a clear margin in breast-conserving therapy is uncertain. The purpose of this study was to correlate the tumor-margin distance of the excision specimen with the presence of residual tumor at reoperation. We also analyzed predictors of compromised margins and of residual disease.
Methods
All patients who underwent breast-conserving therapy for invasive disease from 1999 to 2003 were reviewed. Pathologic characteristics and the precise tumor distance from the radial margin were recorded. A radial margin was compromised if invasive or (ductal) in situ carcinoma was <5 mm from the margin.
Results
Of the 612 patients who underwent breast conservation, 211 (34%) had compromised margins, and 39 had undetermined margins. Of the 161 patients who had a reoperation for compromised margins, 87 (54%) had residual disease. Residual disease after reoperation was present in 58% (56 of 96), 56% (9 of 16), and 45% (22 of 49) of those with tumor-margin distances <1 mm, ≥1 and <2 mm, and ≥2 and <5 mm, respectively. There was a progressive decline in residual disease for each millimeter until a rate of 22% for tumor-margin distances of ≥4 mm and <5 mm was reached. Pathologic size (P = .004), an extensive intraductal component (P = .002), referral from a symptomatic rather than a population-based screening program (P = .02), and the absence of a preoperative diagnosis by core biopsy (P < .0001) were predictive of compromised margins. Only young age (<45 years) was predictive of finding residual disease on reoperation (P = .02).
Conclusions
A total of 45% of patients who had tumor 2 to 5 mm from the radial margin had residual disease on reoperation. Our results support a policy of requiring a 5-mm margin in patients undergoing breast-conserving therapy for invasive disease.
Similar content being viewed by others
References
Taghian A, Mohiuddin M, Jagsi R, Golberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005;241:629–39
Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668–75
Spivack B, Khanna MM, Tafra L, Juillard G, Giuliano AE. Margin status, local recurrence after breast conserving therapy. Arch Surg 1994;129:952–7
Schnitt SJ, Connolly JL, Khettry U, et al. Pathological findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 1987;59:675–81
Beron PJ, Horwitz EM, Martinez AA, et al. Pathologic and mammographic findings predicting the adequacy of tumour excision before breast-conserving therapy. AJR Am J Roentgenol 1996;167:1409–14
Tartter PI, Kaplan J, Bleiweiss I, et al. Lumpectomy margins, reexcision, and local recurrence of breast cancer. Am J Surg 2000;179:81–85
Gage I, Schnitt SJ, Nixon AJ, et al. Pathological margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996;78:1921–28
Jardines L, Fowble B, Schultz D, et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery 1995;118:803–809
Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual disease. Int J Radiat Oncol Biol Phys 1999;45:885–91
Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Predictors of re excision findings, recurrence after breast conservation. Int J Radiat Oncol Biol Phys 2003;57:979–85
Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993;218:22–8
Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer 1995;77:259–67
Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746–51
Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumour recurrence predict disease-specific survival after breast conserving therapy. Cancer 2003;97:926–33
Leong C, Boyages J, Jayasinghe UP, et al. Effects of margins on ipsilateral breast tumour recurrence after breast conservation therapy for lymph node negative breast carcinoma. Cancer 2004;100:1823–32
Pittinger TP, Maronian NC, Poulter CA, Peacock JL. Importance of margin status in outcome of breast-conserving surgery for carcinoma. Surgery 1994;116:605–9
Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383–93
Solin LJ, Fowble B, Martz K, Goodman RL. Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1986;12:721–25
Millar AR, Brandao G, Prihoda TJ, Hill C, Cruz AB, Yeh I. Positive margins following surgical resection of breast carcinoma: analyses of pathological correlates. J Surg Oncol 2004;86:134–40
Cellini C, Hollenbeck ST, Christos P, et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol 2004;11:915–20
Gwin JL, Eisenberg BL, Hoffman JP, Ottery FD, Boraas M, Solin LJ. Incidence of gross, microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 1993;218:729–34
Landheer MLEA, Klinkenberg JHG, Pasker-de Jong PCM, Wobbes T. Residual disease after excision of non-palpable breast tumours: analysis of tumour characteristics. Eur J Surg Oncol 2004;30:824–8
Holland R, Connolly J, Gelman R, et al. The presence of an extensive intraductal component following a limited resection correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113–8
The Royal College of Pathologists. NHS Cancer Screening Programmes. Pathology Reporting of Breast Disease. NHS BSP Publication No. 58. 2005. Available: http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58-high-resolution.pdf
Holland R, Veling SH, Mravunac M, Hendriks JH. Histological multifocality of Tis T1-2 breast carcinomas. Cancer 1985;56:979–90
Ryoo MC, Kagan AR, Wollin M, et al. Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma. Radiology 1989;172:555–9
Horiguchi J, Iino Y, Takei H, et al. Surgical margin and breast recurrence after breast- conserving therapy. Oncol Rep 1999;6:135–8
Bedwinek J. Breast conserving surgery, irradiation: the importance of demarcating the excision cavity with surgical clips. Int J Radiat Oncol Biol Phys 1993;26:675–9
Dillon MF, Hill AD, Quinn C, et al. Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer. J Med Screen 2004;11:130–4
Jacquemier J, Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM. An assessment of extensive intraductal component as a risk factor for local recurrence after breast conserving therapy. Br J Cancer 1990;61:873–6
Vicini FA, Eberlein TJ, Connolly JL, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991;214:200–5
Schnitt SJ, Connolly JL. Processing, evaluation of breast excision specimens. A clinically orientated approach. Am J Clin Pathol 1992;98:125–37
Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathological findings from the National Surgical Adjuvant Breast Cancer Project (protocol 6) II: relation of local breast recurrence to multicentricity. Cancer 1986;57:1717–24
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dillon, M.F., Hill, A.D.K., Quinn, C.M. et al. A Pathologic Assessment of Adequate Margin Status in Breast-Conserving Therapy. Ann Surg Oncol 13, 333–339 (2006). https://doi.org/10.1245/ASO.2006.03.098
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2006.03.098